In this study, 12 different indole‐substituted maleimide derivatives were designed, synthesized, and MTT tests were performed in two different breast cancer cell lines (MCF‐7 and MDA‐MB‐231) to determine their GSK‐3β inhibitor activities. Here, GSK3B is linked to breast carcinoma.